Insider Activity of Zoetis Inc. (NYSE:ZTS)

4

Zoetis Inc. (NYSE:ZTS) currently has a “Hold” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Sell” signal. 10 – 8 Day Moving Average Hilo Channel shows “Hold” signal. While 20-Day Moving Average VS Current Price shows “Sell” Signal.

Zoetis Inc. (NYSE:ZTS) gained 1.15 Percent and closed its previous trading session at $85.47. The stock traded with the average Volume of 2.5 Million at the end of last session.

Zoetis Inc. (NYSE:ZTS) has the Market Capitalization of 41.53 Billion. The Stock has its 52-week High of $89.25 and 52-Week Low of $59.50 and it touched its 52-week high on 06/15/18 and 52-Week Low on 08/08/17

.

The company reported its last earnings Actual EPS of $0.75/share. While, the analyst predicted that the company could provide an EPS of $0.69/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.06/share which shows an Earnings Surprise of 8.7 Percent.

Sell side analysts plays vital role in buying and selling a stock where 4 analysts rated Zoetis Inc. (NYSE:ZTS) as Buy, 0 analysts given Outperform signal, 1 reported Hold, and 1 analysts rated the stock as Sell.

The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -0.95% where SMA50 and SMA200 are 0.68% and 10.6% respectively.

The company shows its Return on Assets (ROA) value of 11.4%. The Return on Equity (ROE) value stands at 52.6%. While it’s Return on Investment (ROI) value is 16%.

Zoetis Inc. (NYSE:ZTS) currently has a Weekly Volatility of 1.44% percent while its Monthly Volatility is at 1.61% percent. While talking about Performance of the Stock, Zoetis Inc. currently has a Weekly performance of -0.79%, monthly performance percentage is -1.93 percent, Quarterly performance is 1.8 percent, 6 months performance shows a percent value of 15.64% and Yearly Performance is 36.62 percent.

Company Profile:

Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.

SHARE